x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2014 > 3rd ESO-ESTRO Masterclass in Radiation Oncology
Print

3rd ESO-ESTRO Masterclass in Radiation Oncology

30 ESCO credits

08.11.2014  -  12.11.2014

Cascais, Portugal

MASTERCLASS

Radiation oncology

Description

Chairs: M. Baumann, DE - J. Bernier, CH - R. Orecchia, IT - R. Pötter, AT


AIMS AND OBJECTIVES
ESO and ESTRO are pleased to announce the third edition of the Masterclass in Radiation Oncology, this year with a renewed format offering a deeper look into the state of art and evidence based innovation strategies in radiation oncology. The programme, focusing on the pillars and on the hot topics in radiation oncology, has been designed to offer a unique learning experience and to provide a practice-oriented training to radiotherapists and to clinical oncologists with knowledge in the field.


TEACHING FORMAT
The programme will offer plenary lectures focusing on the state-of-the-art treatments and opportunities to integrate emerging technologies and basic research results in innovative clinical strategies. Furthermore, participants
will present an innovation or research proposal outlining novel developmental work (physics, imaging, biology, QA, etc.) with a clinically relevant question and study design (first in man, early phase or later phase) that considers the multidisciplinary environment.
All participants will reside at the course venue and their participation is compulsory throughout the course, with its approximately 30 hours of programme.
The Masterclass will be entirely in English and fluency in English is compulsory for admission.


THE MASTERCLASS IS:
• 4-day residential educational event
• Full immersion in radiation oncology
• Clinically-oriented training
• Multidisciplinary
• International faculty of top experts delivering lectures
• Meet-the-expert workshops



    

The Masterclass in
Radiation Oncology is an
ESO-ESTRO joint event

   

General information

INFORMATION
Gabriella Axelsson
ESTRO European Society for Radiotherapy and Oncology
Rue Martin V, 40
1200 Brussels - Belgium
Tel.: +32 2 775 9351
Fax: +32 2 779 5494
e-mail: GAxelsson@estro.org
www.estro.org


Rita De Martini
European School of Oncology (ESO)
Via Turati, 29
20121 Milan - Italy
e-mail: rdemartini@eso.net
Tel: + 39 02 85464527



ACCREDITATION
The Accreditation Council of Oncology in Europe (ACOE) and the European Accreditation Council for Continuing Medical Education (EACCME) have acknowledged the quality of the scientific programme and its educational value. The 3rd ESO-ESTRO Masterclass in Radiation Oncology has been assigned 24 European Continuing Medical Education Credits (ECMEC).
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.amaassn.org/go/internationalcme.






.

Faculty list


FACULTY
M. Baumann, Clinic and Policlinic for Radiotherapy, University Hospital Carl Gustav Carus, Technische
Universitaet Dresden, DE
J. Belderbos, NKI Netherlands Cancer Institute, Amsterdam, NL
S.M. Bentzen, Division of Biostatistics and Bioinformatics, University of Maryland School of Medicine, Baltimore MD, US
J. Bernier, Department of Radiotherapy, Clinique de Genolier, CH
A.L. Børresen-Dale, Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital Oslo, NO
F. Calvo, Department of Oncology, Hospital General Universitario Gregorio Maranon, Madrid, ES
M. Krause, Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universitaet
Dresden, DE
R. Orecchia, Division of Radiotherapy, European Institute of Oncology, Milan, IT
R. Pötter, Department of Radiotherapy and Radiobiology Medical University, General Hospital of Vienna, AT
S. Popat, Department of Medical Oncology, Royal Marsden Hospital, London, UK
P. Sloan, Department of Cellular Pathology, Newcastle University, Royal Victoria Infirmary,
Newcastle upon Tyne, UK
D. Thorwarth, Department of Radiation Oncology, University Hospital Tübingen, DE
C. van de Velde, Department of Surgery, University Hospital, Leiden, NL
J.B. Vermorken, Department of Oncology, University Hospital Antwerp Edegem, BE
D. Zips, Uniklinik fur Radioonkologie, Tubingen, DE




Programme


8 November

   
  Arrivals
11:30
Registration and buffet lunch
SESSION 1: TECHNOLOGY - IMAGES
Chair: D. Zips, DE
13:00
Technology research, more related to treatment planning
D. Thorwarth, DE
14:00
Emerging technologies (Hadron, but not only, broader approach)
R. Orecchia, IT
15:30
Coffee break
16:00
Technology oriented trials:
How to provide evidence for technologies

R. Pötter, AT
17:00
Elaborated trials studies on technology testing.
Innovation in RO, new research approach

D. Zips, DE
18:00
End of the day
20:00
Welcome drink and dinner

 

9 November

   
  8:30 Parallel session on TECHNOLOGY:
How to bring the trials discussed in existence (3 group sessions)

10:00
 Coffee break
 10:30 Parallel sessions continued
12:00
 Take home messages
12:30
 Lunch
SESSION 2: METHODOLOGY
Chair: M. Baumann, DE
13:30 Radiation oncology research: introduction
D. Zips, DE
14:00
 Research designs for evidence-based radio-oncology
(including retrospective analyses)

S. Bentzen, US
 15:00 Coffee break
16:30
 Research designs for evidence-based radio-oncology
(including retrospective analyses)

S. Bentzen, US
17:30
 End of the day
20:00
 Dinner
   

 

10 November

   
 8:30 Parallel session METHODOLOGY:
Questions to be discussed in groups about research design, added
value of transplantation research (3 groupes sessions)

10:00
 Coffee break
10:30
 Parallel sessions continued
12:00
 Take home messages
12:30
 Lunch
SESSION 3: BIOLOGY
Chair: M. Krause, DE
 13:30 New insights into biology relevant for translational trials in
radiation oncology

A.L. Børresen-Dale, NO
14:30
 Biomarkers
M. Krause, DE
 15:30 Coffee break
16:00
 What’s emerging in systemic treatment
S. Popat, UK
 17:00 Combined treatment, biological endpoint
M. Krause, DE
 18:00 Pathology
P. Sloan, UK
19:00
 End of the day
  Free evening
   

 

11 November

   
 8:30 Parallel session - BIOLOGY: How can we integrate biology questions
into translational and clinical trial protocols (3 group sessions)

10:00
 Coffee break
10:30
 Parallel sessions continued
12:00
 Take home messages
 12:30  Lunch
SESSION 4: MULTIDISCIPLINARY
The importance of the multidisciplinary approach

Chair: J. Bernier, CH
13:30
 Introductory talk: Multidisciplinary development of trials
J. Belderbos, NL
14:30
 Drug radiation: Clinical applications of drug-radiation interactions
J. Bernier, CH
15:30
 Coffee break
16:00
 Medical oncology approach: Combining local and systemic
treatments - Is more always better?

J.B. Vermorken, BE
17:00
 Surgical approach
C. Van de Velde, NL
18:00
 End of the day
20:00
 Social dinner
   

 

12 November

   
8:30
Parallel session: Multidisciplinary (3 group sessions)
10:00
Coffee break
10:30
Parallel sessions continued
12:00
Take home messages
12:30
Final remarks
13:00
Handing out of certificate (the certificate will be available through
the event dedicated website)



Buffet lunch
14:00
Departures
   

 

 

 

Follow us